Trial evaluating safety and efficacy of Staccato Alprazolam in subjects with epilepsy and a predictable seizure pattern Results from the open label portion of the study will be presented at a major medical meeting in 2019 NEW ORLEANS, Dec. 03, …
Latest News From Lumira Ventures
Antios Therapeutics Raises $25 Million in Oversubscribed Series A Financing to Pursue Hepatitis B Cure
International Group of Investors from Canada, the U.S. and China Support Former Senior Executives from Pharmasset and Idenix in New Venture ATLANTA, Nov. 27, 2018 /PRNewswire/ — Antios Therapeutics, Inc. (“Antios”) today announced the completion of a US$25 million oversubscribed …
Cardiac Dimensions Announces DRG Reimbursement Code for Carillon® Mitral Contour System® in Germany
With Reimbursement in Place and Positive Late-Breaking Data, Company Expects Continued Growth in Germany Kirkland, Wash. – October 18, 2018 – Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related …
Exact Imaging Announces Health Canada Approval for its FusionVu™ Application for Micro-Ultrasound/MRI Fusion
ExactVu™ micro-ultrasound platform – now with FusionVu – enables the highest real-time resolution for targeted prostate imaging and biopsy Exact Imaging, the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announced it …
Lumira Ventures. Rebranded.
Today, Lumira Ventures is excited to debut its new website at www.lumiraventures.com, new branding and change of name from Lumira Capital to Lumira Ventures. Over the past 30 years, Lumira has been at the forefront of the healthcare investment industry. …